Learn how to collaboratively manage thyroid eye disease (TED). This interactive, case-based CME symposium brings together endocrinologists and oculoplastic surgeons to tackle real-world challenges—when to refer, who manages which aspects of care, and how to coordinate treatment—to improve outcomes in patients with both active and chronic TED.
advertisement
The TED Lasso Approach: Coaching Collaboration in Thyroid Eye Disease
Join Drs. Khachikian, Gupta, Kikkawa, and Ko in this case-based symposium as they explore best practices in the collaborative care of patients with TED.
Live
Broadcast
1.00 available credits
Information
September 13, 2025
09:30 AM - 10:30 AM ET
Virtual
Share
This broadcast will start in exactly:
- 0
Day(s)
- 0
Hour(s)
- 0
Minute(s)
- 0
Second(s)
Share
Share
Share this program on:
Details
Presenters
Target Audience
This activity has been designed to meet the educational needs of endocrinologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with thyroid eye disease.
Grantor Statement
This activity is supported by an independent educational grant from Amgen, Inc.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Interpret clinical signs of TED to guide patient evaluation and long-term disease monitoring
- Assess the suitability of biologic therapy for patients with TED based on clinical presentation and key considerations related to efficacy and safety
- Recommend interdisciplinary care strategies for TED, including effective coordination with ophthalmology
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Faculty
Sonalika Khachikian, MD
Department Chair
Division of Endocrinology
Monument Health Rapid City Clinic
Rapid City, SD
Malini Gupta, MD, ECNU, FACE
Director of G2Endo
Memphis, TN
Don Kikkawa, MD, FACS
Trude Kahn Hollander Chair, Ophthalmology
Chief, Oculofacial Plastic/Reconstructive Surgery
University of California
San Diego School of Medicine
La Jolla, CA
Audrey Ko, MD
Oculofacial Plastic and Reconstructive Surgeon
Wolfe Eye Clinic
Des Moines, IADisclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Sonalika Khachikian, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Viridian Pharmaceuticals. Speaker’s Bureau: Amgen.
Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureau: Amgen, Ascendis, Chiesi, IBSA.
Don Kikkawa, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acerlyrin, Amgen, Argenx, Immunovant, Lassen, Viridian. Grant/Research Support: LIDS Clinical Trial, SLING Phase II.
Audrey Ko, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen. Grant/Research Support: SLING. Speaker’s Bureau: Amgen.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Details
Presenters
Overview
Learn how to collaboratively manage thyroid eye disease (TED). This interactive, case-based CME symposium brings together endocrinologists and oculoplastic surgeons to tackle real-world challenges—when to refer, who manages which aspects of care, and how to coordinate treatment—to improve outcomes in patients with both active and chronic TED.
Target Audience
This activity has been designed to meet the educational needs of endocrinologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with thyroid eye disease.
Grantor Statement
This activity is supported by an independent educational grant from Amgen, Inc.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Interpret clinical signs of TED to guide patient evaluation and long-term disease monitoring
- Assess the suitability of biologic therapy for patients with TED based on clinical presentation and key considerations related to efficacy and safety
- Recommend interdisciplinary care strategies for TED, including effective coordination with ophthalmology
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Faculty
Sonalika Khachikian, MD
Department Chair
Division of Endocrinology
Monument Health Rapid City Clinic
Rapid City, SD
Malini Gupta, MD, ECNU, FACE
Director of G2Endo
Memphis, TN
Don Kikkawa, MD, FACS
Trude Kahn Hollander Chair, Ophthalmology
Chief, Oculofacial Plastic/Reconstructive Surgery
University of California
San Diego School of Medicine
La Jolla, CA
Audrey Ko, MD
Oculofacial Plastic and Reconstructive Surgeon
Wolfe Eye Clinic
Des Moines, IADisclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Sonalika Khachikian, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Viridian Pharmaceuticals. Speaker’s Bureau: Amgen.
Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureau: Amgen, Ascendis, Chiesi, IBSA.
Don Kikkawa, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acerlyrin, Amgen, Argenx, Immunovant, Lassen, Viridian. Grant/Research Support: LIDS Clinical Trial, SLING Phase II.
Audrey Ko, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen. Grant/Research Support: SLING. Speaker’s Bureau: Amgen.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Recommended
nAMD Cases & Clinical Conversations - Part 2
nAMD Cases & Clinical Conversations - Part 2
CME/CE Broadcast ReplaynAMD Cases & Clinical Conversations - Part 2
1.00 credit
Sunir J. Garg, MD, FACS, FASRS
Olufemi E. Adams, MD
Nikhil K. Bommakanti, MD
Anthony Obeid, MD, MPH
Michael Yu, MD
1.00 credit